A Mitochondrial Supplement Trial in Autism – A Research Update from Dr. Richard Frye
Dr. Richard E. Frye walks through a double-blind, placebo-controlled crossover trial of a mitochondrial supplement in children with autism. Paper: Hill et al., "A Mitochondrial Supplement Improves Function and Mitochondrial Activity in Autism," IJMS 2025.
How Gut Bacteria Talk to Mitochondria – A Research Update from Dr. Richard Frye
Dr. Richard E. Frye walks through a new review of how gut bacteria affect mitochondria, the structures that make energy inside nearly every cell. Paper: Frye & Rossignol, "Mechanistic Pathways Linking Gut Microbial Metabolites, Microbial Structural Products, and Host-Microbe Co-Metabolites to Mitochondrial Function," Gut Microbes 2026.
What Baby Teeth Can Teach Us About Prenatal Care – A Research Update from Dr. Richard Frye
Dr. Richard E. Frye walks through research that reads a pregnancy out of a baby tooth, showing atypical fetal inflammatory regulation in autism. Paper: Dumitriu et al., "Deciduous Tooth Biomarkers Reveal Atypical Fetal Inflammatory Regulation in Autism Spectrum Disorder," iScience 2023.
De Novo Mutations in Autism – A Research Update from Dr. Richard Frye
Dr. Richard E. Frye walks through new research on de novo mutations in autism: genetic changes present in a child but in neither parent. Paper: Boles et al., "De Novo Variants Predominate in Autism Spectrum Disorder," Genes 2025.
Folate Antibodies Across Generations – A Research Update from Dr. Richard Frye
Dr. Richard E. Frye walks through new research on folate receptor alpha autoantibodies and how they appear to build from one generation to the next. Paper: Frye et al., "Transgenerational Effects and Heritability of Folate Receptor Alpha Autoantibodies in Autism Spectrum Disorder," IJMS 2025.
Folate and the Microbiome – A Research Update from Dr. Richard Frye
Dr. Richard E. Frye walks through a new systematic review of how gut bacteria make and consume folate, and what happens to health when that balance breaks down. Paper: Khanduja & Frye, "A Systematic Review of Folate and the Human Enteric Microbiome," IJMS 2026.
Children with autism are showing ‘dramatic improvement’ with this cheap drug — and doctor behind its research says it may one day prevent the disorder
By McKenzie Beard Published March 19, 2025, 6:00 a.m. ET
Autism: Arizona doctor claims new drug is helping patients | FOX 10 Phoenix
There is new hope regarding a possible treatment for autism, and it is being spearheaded by a doctor in the Phoenix area.
Child Neurologist Richard Frye has been testing the generic drug Leucovorin as a way of helping folic acid get through to the brain. Folic acid is essential for brain development. Dr. Frye said many patients saw significant improvements in their language skills.
"It's not just talking, but, what we found in our testing is that they were able to understand language in a more complicated fashion and understand the social nuances of language," Dr. Frye said.
Dr. Frye has published his findings in a book, as well as in peer-reviewed studies, and he hopes for additional outside research to confirm and expand on what may be a promising new treatment. FOX 10's Ellen McNamara has more.
(This video is provided for educational and informational purposes only, and does not constitute providing medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.)
Doctor claims new drug helps treat children with autism | FOX 5 News
A neurologist in Arizona says the generic drug leucovorin help children with autism absorb folic acid, allowing their brains to develop in a more neuro-typical way. The FDA has not approved the drug for this purpose though.
Parents say son with autism was nonverbal until trying an off-label drug that treats chemo side effects
content
TACA provides education, support, and hope to families living with autism. Thank you for your support.
